FDA Investigator Marshalette O Edwards
Marshalette O Edwards has inspections in 4 countries as of 15 Sep 2023. Marshalette O Edwards has collaborated with a combinined 2032 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
30
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Germany,
Switzerland
Co-Investigator(s):
Alice S Tsao,
Alla Dubrovsky,
Almogela,
Amir Alavi,
Andersoneric,
Andrew K Haack, PhD,
Andrew Lin,
Andrew P Lin,
Anh M Lac,
Anita Narula, PhD,
Arsen Karapetyan,
Ashar P Parikh,
Azza Talaat,
Barbara M Frazier,
Bo Chi, PhD,
Bonita S Chester,
Carl Lee,
Carolyn A Renshaw,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Concepcion Cruz, Jr,
Daniel C Geffin,
Daniel J Roberts,
Darlene B Almogela,
David G Eng,
Dr. Robert C Horan, MD,
Edna J Hidalgo,
Emal Wahab,
Felix Maldonado,
Gerald N Mcgirl, DDS,
Gina M Hall,
Gunneet Kaur,
Henry K Lau,
Italia Nappi,
James C Lee, PharmD,
James R Evans,
Jane G Choi,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jeffrey W Shrifter, DPM,
Jeffrey Watson,
Jennifer Crumb,
Jennifer L Johnson,
Joanne Hosting,
Joanne Hostings,
John A Gonzalez,
Jolanna A Norton,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Karen D Phung,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kenneth O Gee, PhD,
Kevin A Gonzalez,
Kevin P Foley,
Kouros Kangarli,
Kristin M Abaonza,
Kumar G Janoria,
Lance M De Souza, MBA,
Lata C Mathew, PhD,
Laurie Graham,
Lija V Fellows,
Linan Ha, PhD,
Lorna F Jones,
Lucila B Nwatu,
Luella J Rossi,
Margaret M Annes,
Marie K Kinkade,
Mariza M Jafary,
Marshalette Edwards,
Matthew A Spataro,
Matthew R Clabeaux,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Minh D Phan,
Monique C Lo,
Mra Mcculloughj,
Natalia Pripuzova, PhD,
Nicholas L Hunt,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Peter E Baker,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Quynh H Strandberg,
Raymond T Oji,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard H Penta,
Robert D Tollefsen,
Ruth Moore, PhD,
Sandra A Hughes,
Sandra S Saniga,
Sarah E Mcmullen,
Scott N Lim,
Sergio Chavez (NMI),
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Sixto M Mercado Rios,
Stephanie A Slater, MS,
Steven D Kehoe,
Ted L Anderson,
Terrence Gee,
Thomas J Arista,
Thomas W Gordon,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Walden H Lee,
William J Foust,
William V Millar,
Yvins Dezan
Marshalette O Edwards's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2000 | EIR | Excella GmbH & Co. KG - EIR, 2000-06-30 |
| October, 2000 | EIR | Impax Laboratories, Inc. - EIR, 2000-10-18 |
| February, 2000 | EIR | Genentech, Inc. - EIR, 2000-02-14 |
| February, 2002 | EIR | BioZone Laboratories Inc. - EIR, 2002-02-20 |
| June, 2002 | EIR | Mylan Specialty, L.P. - EIR, 2002-06-25 |
| October, 2000 | FDA 483 | IMDA Laboratories, Inc. - Form 483, 2000-10-18 |
| July, 2001 | EIR | Scios Inc - EIR, 2001-07-10 |
| June, 2000 | FDA 483 Response | Excella GmbH & Co. KG - Form 483R, 2000-11-14 |
| February, 2000 | FDA 483 | Genentech, Inc. - Form 483, 2000-02-14 |
| February, 2001 | EIR | Impax Laboratories, Inc. - EIR, 2001-02-05 |
| November, 2000 | EIR | Bausch Health Americas, Inc. - EIR, 2000-11-06 |
| January, 2000 | EIR | Alza Corp - EIR, 2000-01-31 |
| July, 2001 | FDA 483 | Scios Inc - Form 483, 2001-07-10 |
| February, 2001 | FDA 483 | Impax Pharmaceuticals - Form 483, 2001-02-05 |
| March, 2002 | EIR | Impax Laboratories, Inc. - EIR, 2002-03-13 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more